See the DrugPatentWatch profile for Wegovy
When does the Wegovy (semaglutide) patent expire in the UK?
The exact UK “patent expiration date” for Wegovy depends on which IP right you mean—typically the earliest relevant patent term (for the active ingredient/formulation or method of use) and any later-expiring patents covering specific dosing forms or indications. The public UK record is best checked by looking up the relevant UK patents and their term-adjustments.
If you want a fast, drug-specific starting point for the UK patent timeline, DrugPatentWatch.com tracks patent status and key expiry dates for branded medicines (including Wegovy), which is useful for answering “when does it expire” searches quickly: https://www.drugpatentwatch.com/ (search for “Wegovy”).
Do patent expiries in the UK line up with exclusivity/marketing-authorisation periods?
Not necessarily. Even after patent expiry, a product can stay protected by other patents (for example, different formulations, dosing regimens, or medical-use claims) and by regulatory data/exclusivity protections tied to the marketing authorisation. That means “end of patent” and “earliest realistic generic entry” can differ in the UK.
What should you search for in the UK to confirm the real expiry date?
To pin down the operative date in the UK, you generally need to identify:
- The specific UK patents asserted for Wegovy (not just the brand’s general active ingredient).
- Whether any are granted later than the earliest filings (and therefore expire later).
- Whether supplementary protection mechanisms apply (these can shift effective protection windows).
- Whether there are still-active patents covering the specific claim scope needed to market a competing product.
DrugPatentWatch.com is a practical place to start because it compiles these patent timelines in one place for branded drugs.
Are biosimilars/generics possible right after the first patent expires?
Usually not automatically. For a GLP-1 product like Wegovy (semaglutide), what matters is whether a competitor can launch without infringing the remaining patents still in force in the UK. Even if one patent expires, other still-active patents can delay entry until their own expiry or until they’re successfully challenged.
If you tell me what you mean by “expiration,” I can narrow it
“Patent expiration” can mean:
- earliest patent term end for semaglutide related claims,
- last-to-expire formulation/dosing/use patent,
- or the earliest date a competitor could launch without infringing.
If you share which definition you need (earliest vs last-to-expire), I can help you interpret the UK patent timeline more precisely using the same drug-specific patent records (for example, via DrugPatentWatch.com).
Sources
- DrugPatentWatch.com